2022-05-19 07:10:40 CDEV Centennial Resource Development
05/19/22 05/1907:10 05/19/2207:10 | Centennial Resource, Colgate Energy to combine in merger of equalsCentennial Resource Development and Colgate Energy Partners III announced they have entered into an agreement to combine in a merger of equals transaction. The combined company will be the largest pure-play E&P company in the Delaware Basin with approximately 180,000 net leasehold acres, 40,000 net royalty acres and total current production of approximately 135,000 Boe/d. The combined company plans to leverage its high-quality, scaled asset base to drive leading shareholder returns. Key Highlights: High-quality, complementary asset base with differentiated inventory depth to support sustainable free cash flow growth; Positioned to significantly increase cash returns to shareholders, with over $1 billion of expected free cash flow in 2023 at current strip prices; Highly accretive to key financial metrics, including cash flow, free cash flow and net asset value per share; Strong balance sheet with expected leverage below 1.0x at year-end 2022; Sean Smith to serve as Executive Chair of the Board; Will Hickey and James Walter to serve as Co-CEOs; Significant equity ownership of combined management team aligns with shareholders; Shared commitment to prioritizing ESG with continued focus on reducing environmental impact. The approximately $7.0 billion merger of equals values Colgate at approximately $3.9 billion and is comprised of 269.3 million shares of Centennial stock, $525 million of cash and the assumption of approximately $1.4 billion of Colgate's outstanding net debt. Given existing cash balances and interim free cash flow, the company expects its net debt-to-LTM EBITDAX ratio at closing to be approximately 1.0x. The cash consideration and the repayment of Colgate's outstanding credit facility borrowings at closing are expected to be funded with cash on hand and borrowings under an upsized revolving credit facility. The transaction has been unanimously approved by the Boards of Directors of both companies and is expected to close in the second half of 2022. The company intends to provide detailed forward-looking guidance for the remainder of 2022 at or shortly after closing of the transaction. Upon closing, Sean Smith will serve as Executive Chair of the Board of Directors of the newly combined business, and Will Hickey and James Walter will lead the company as Co-CEOs and will serve on the Board of Directors. Matt Garrison, Centennial's current Chief Operating Officer, and George Glyphis, Centennial's current Chief Financial Officer, will continue to serve in their respective roles at the combined company. The combined company will be headquartered in Midland, with key positions filled by representatives from both companies. The Denver office will remain open for the foreseeable future to ensure continuity and continued operational success. The combined company will operate under a new name and stock ticker symbol, which are expected to be announced prior to closing. Following the merger, Centennial's Board of Directors will be expanded to eleven directors, consisting of Sean Smith, Will Hickey, James Walter, William Quinn and Robert Tichio, in addition to six independent directors. Immediately following the closing, existing Centennial shareholders will own approximately 53% of the combined company, and existing Colgate owners will own approximately 47% of the combined company. Centennial's largest shareholder, Riverstone, which currently owns approximately 25% of Centennial's outstanding shares, has executed a Voting and Support Agreement in connection with the transaction. The closing of the merger is subject to customary closing conditions, including approval by Centennial shareholders and regulatory approvals. |
|
---|
Downgrade
|
Lennar downgraded to Neutral from Outperform at Wedbush »
07:25 08/12/22 08/1207:25 08/12/2207:25
LEN
Lennar
Wedbush analyst Jay… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
GreenLight Bioscences announces $109M financing »
07:25 08/12/22 08/1207:25 08/12/2207:25
GRNA
GreenLight Bioscences
GreenLight Biosciences… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
ARC Group says RM2 continues to experience 'record demand' for BLOCKPal pallets »
07:22 08/12/22 08/1207:22 08/12/2207:22
ARCW
ARC Group
ARC Group Worldwide… Story temporarily locked. |
Hot Stocks
|
Aptinyx announces NYX-2925 study did not achieve primary endpoint »
07:22 08/12/22 08/1207:22 08/12/2207:22
APTX
Aptinyx
Aptinyx announced results… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Unity: UBX1325 injection led to clinically meaningful improvement in mean BCVA »
07:20 08/12/22 08/1207:20 08/12/2207:20
UBX
Unity Biotechnology
UNITY Biotechnology… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Diebold downgraded to Underweight from Neutral at JPMorgan »
07:20 08/12/22 08/1207:20 08/12/2207:20
DBD
Diebold
JPMorgan analyst Paul… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Plexus downgraded to Underweight from Neutral at JPMorgan »
07:20 08/12/22 08/1207:20 08/12/2207:20
PLXS
Plexus
JPMorgan analyst Paul… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Cognex downgraded to Underweight from Neutral at JPMorgan »
07:19 08/12/22 08/1207:19 08/12/2207:19
CGNX
Cognex
JPMorgan analyst Paul… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Six Flags price target lowered to $28 from $35 at Stifel »
07:18 08/12/22 08/1207:18 08/12/2207:18
SIX
Six Flags
Stifel analyst Steven… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Unity Biotechnology announces anticipated milestones »
07:17 08/12/22 08/1207:17 08/12/2207:17
UBX
Unity Biotechnology
UBX1325 24-week safety… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Toast price target raised to $25 from $18 at KeyBanc »
07:17 08/12/22 08/1207:17 08/12/2207:17
TOST
Toast
KeyBanc analyst Josh Beck… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
PLx Pharma announces survey data on VAZALORE 81 mg »
07:17 08/12/22 08/1207:17 08/12/2207:17
PLXP
PLx Pharma
PLx Pharma, with its lead… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Unity Biotechnology expects cash to fund operations through 1Q23 »
07:17 08/12/22 08/1207:17 08/12/2207:17
UBX
Unity Biotechnology
Cash, cash equivalents… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Illumina price target lowered to $300 from $480 at Stifel »
07:16 08/12/22 08/1207:16 08/12/2207:16
ILMN
Illumina
Stifel analyst Daniel… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Unity Biotechnology reports Q2 EPS (19c) vs. (32c) last year »
07:16 08/12/22 08/1207:16 08/12/2207:16
UBX
Unity Biotechnology
Reports Q2 revenue… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
CS Disco price target lowered to $30 from $40 at Stifel »
07:15 08/12/22 08/1207:15 08/12/2207:15
LAW
CS Disco
Stifel analyst J. Parker… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Real Good Food raises FY22 revenue $155M-$160M from $150M-$160M »
07:15 08/12/22 08/1207:15 08/12/2207:15
RGF
Real Good Food
FY22 revenue consensus… Story temporarily locked. ShowHide Related Items >><<
|
General news
| Market Update: Stock… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Venus Concept sees 2022 revenue $110M-$113M, consensus $126.82M »
07:14 08/12/22 08/1207:14 08/12/2207:14
VERO
Venus Concept
The Company now expects… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Venus Concept reports Q2 EPS (16c), consensus (7c) »
07:14 08/12/22 08/1207:14 08/12/2207:14
VERO
Venus Concept
Reports Q2 revenue… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Cellebrite downgraded to Market Perform at William Blair after guidance cut »
07:14 08/12/22 08/1207:14 08/12/2207:14
CLBT
Cellebrite
William Blair analyst… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Real Good Food reports Q2 revenue $30.809M, consensus $32.12M »
07:14 08/12/22 08/1207:14 08/12/2207:14
RGF
Real Good Food
"I am pleased with… Story temporarily locked. ShowHide Related Items >><<
|
Syndicate
|
Vigil Neuroscience announces $75M private placement finanicng »
07:13 08/12/22 08/1207:13 08/12/2207:13
VIGL
Vigil Neuroscience
Vigil Neuroscience… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Brilliant Earth price target raised to $10 from $8 at KeyBanc »
07:13 08/12/22 08/1207:13 08/12/2207:13
BRLT
Brilliant Earth
KeyBanc analyst Noah… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Aslan Pharmaceuticals reports Q2 EPS (4c) vs (2c) last year »
07:12 08/12/22 08/1207:12 08/12/2207:12
ASLN
Aslan Pharmaceuticals
Cash, cash equivalents… Story temporarily locked. ShowHide Related Items >><<
|